1. Home
  2. ARQQ vs LEXX Comparison

ARQQ vs LEXX Comparison

Compare ARQQ & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQQ
  • LEXX
  • Stock Information
  • Founded
  • ARQQ 2017
  • LEXX 2004
  • Country
  • ARQQ United Kingdom
  • LEXX Canada
  • Employees
  • ARQQ N/A
  • LEXX N/A
  • Industry
  • ARQQ Computer Software: Prepackaged Software
  • LEXX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARQQ Technology
  • LEXX Health Care
  • Exchange
  • ARQQ Nasdaq
  • LEXX Nasdaq
  • Market Cap
  • ARQQ 531.6M
  • LEXX 19.6M
  • IPO Year
  • ARQQ N/A
  • LEXX N/A
  • Fundamental
  • Price
  • ARQQ $37.94
  • LEXX $0.82
  • Analyst Decision
  • ARQQ Strong Buy
  • LEXX Strong Buy
  • Analyst Count
  • ARQQ 1
  • LEXX 1
  • Target Price
  • ARQQ $52.00
  • LEXX $5.00
  • AVG Volume (30 Days)
  • ARQQ 1.3M
  • LEXX 89.7K
  • Earning Date
  • ARQQ 05-22-2025
  • LEXX 07-14-2025
  • Dividend Yield
  • ARQQ N/A
  • LEXX N/A
  • EPS Growth
  • ARQQ N/A
  • LEXX N/A
  • EPS
  • ARQQ 0.48
  • LEXX N/A
  • Revenue
  • ARQQ $241,000.00
  • LEXX $615,923.00
  • Revenue This Year
  • ARQQ $1,818.77
  • LEXX $6.04
  • Revenue Next Year
  • ARQQ N/A
  • LEXX $8.36
  • P/E Ratio
  • ARQQ $78.16
  • LEXX N/A
  • Revenue Growth
  • ARQQ N/A
  • LEXX 49.85
  • 52 Week Low
  • ARQQ $3.72
  • LEXX $0.81
  • 52 Week High
  • ARQQ $52.79
  • LEXX $4.38
  • Technical
  • Relative Strength Index (RSI)
  • ARQQ 58.09
  • LEXX 32.80
  • Support Level
  • ARQQ $34.50
  • LEXX $0.86
  • Resistance Level
  • ARQQ $41.40
  • LEXX $1.05
  • Average True Range (ATR)
  • ARQQ 3.69
  • LEXX 0.05
  • MACD
  • ARQQ -0.55
  • LEXX 0.00
  • Stochastic Oscillator
  • ARQQ 50.27
  • LEXX 0.14

About ARQQ Arqit Quantum Inc.

Arqit Quantum Inc is a cybersecurity company that has pioneered a symmetric key agreement technology that makes the communications links of any networked device or data at rest secure against current and future forms of cyber attack - even an attack from a quantum computer. The company delivers its symmetric key agreement technology via its product SKA-Platform. The firm operates in one segment that is, the provision of cybersecurity services. The company operates and generates its revenue from UK.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

Share on Social Networks: